Page 6 - Read Online
P. 6
18 Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a western perspective
Ann Farrell, Marno Ryan, Jessica Howell
Hepatoma Res 2020;6:18 http://dx.doi.org/10.20517/2394-5079.2019.019
19 Diagnosing non-hepatocellular carcinoma malignancies on CT/MRI and contrast enhanced ultrasound:
the Liver Imaging Reporting and Data System approach
Kathryn J. Fowler, Guilherme Moura Cunha, Tae Kyoung Kim
Hepatoma Res 2020;6:19 http://dx.doi.org/10.20517/2394-5079.2020.21
20 Hepatocellular carcinoma and hepatitis C virus infection in Latin America: epidemiology, diagnosis and
treatment
Marina Galicia-Moreno, Hugo Christian Monroy-Ramirez, Marina Campos-Valdez, Jaime Sanchez-Meza, Laura
Sanchez-Orozco, Juan Armendariz-Borunda
Hepatoma Res 2020;6:20 http://dx.doi.org/10.20517/2394-5079.2019.36
21 The impact of direct-acting antivirals on hepatitis C associated hepatocellular carcinoma
Tai-Ping Lee, David Bernstein
Hepatoma Res 2020;6:21 http://dx.doi.org/10.20517/2394-5079.2019.44
22 Direct-acting antivirals and risk of hepatocellular carcinoma: from genetic signature to metabolic risk
factors
Stefano Gitto, Erica Villa
Hepatoma Res 2020;6:22 http://dx.doi.org/10.20517/2394-5079.2019.50
23 Personalized T-cell therapy in liver transplanted patients with hepatitis B virus related hepatocellular
carcinoma
Morteza Hafezi, Antonio Bertoletti, Anthony Tan
Hepatoma Res 2020;6:23 http://dx.doi.org/10.20517/2394-5079.2020.02
24 Recent advances regarding tumor microenvironment and immunotherapy in hepatocellular carcinoma
Wei Qin, Zhen-Yu Cao, Si-Yuan Liu, Xun-Di Xu
Hepatoma Res 2020;6:24 http://dx.doi.org/10.20517/2394-5079.2020.04
25 The advancement of immunotherapy in hepatocellular carcinoma
Ling Ni, Yu Feng, Chen Dong
Hepatoma Res 2020;6:25 http://dx.doi.org/10.20517/2394-5079.2020.14
26 Treatment options for recurrence of hepatocellular carcinoma after surgical resection: review of the
literature and current recommendations for management
Francesco Pasini, Matteo Serenari, Alessandro Cucchetti, Giorgio Ercolani
Hepatoma Res 2020;6:26 http://dx.doi.org/10.20517/2394-5079.2019.47
27 Mechanisms and immunotherapies of HBV- and NAFLD-related hepatocellular carcinoma
Xiao-Jia Song, Chun-Hong Ma
Hepatoma Res 2020;6:27 http://dx.doi.org/10.20517/2394-5079.2020.05
